Deborah J Levine MD
Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease, Pulmonary Vascular Medicine
Professor, Medicine, University of Texas Medical School, San Antonio Medical Director Lung Transplantation Director of Pulmonary Hypertension Center
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 210-450-6018
Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2003
University of Arizona College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2022 - 2026
AZ State Medical License 1999 - 2024
TX State Medical License 2005 - 2023
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Pregnancy After Solid Organ Transplantation: Review of the Evidence and Recommendations.Goni Katz-Greenberg, Yalda Afshar, Julie Bonn, Jillian Casale, Serban Constantinescu
Transplantation. 2025-09-01 - Diagnostic significance of intragraft donor-specific anti-HLA antibodies in pulmonary antibody-mediated rejection.Sandrine Hirschi, Guilaine Hell, Deborah Jo Levine, Benjamin Coiffard, Francois Severac
The Journal of Heart and Lung Transplantation. 2025-08-21 - Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force.Jon Kobashigawa, Josh Levitsky, Neeraj Singh, Kiran Khush, Sean Pinney
American Journal of Transplantation. 2025-08-01
Journal Articles
- Banff Lung Report: Current Knowledge and Future Research Perspectives for Diagnosis and Treatment of Pulmonary Antibody Mediated Rejection (AMR)Deborah Levine, MD, American journal of transplantation
Press Mentions
TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business UpdateAugust 12th, 2021- Health: Women Experience 'Significantly Faster' Declines in Cognition Than MenFebruary 26th, 2021
- ‘We’re Poised to Do It’: University Hospital to Perform Double Lung Transplants for COVID-19 Patients with Irreversible Lung DamageOctober 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
